Study | Area, Study-time | Prevalence(N) | Age | R/L | Focus |
---|---|---|---|---|---|
Frommelt PC, 2011 [10] | America, 1999–2009 | NA (27) | 55.3 ± 13.5 | 20/7 | B |
Mumtaz MA, 2011 [11] | America, 1998–2008 | NA (22) | 15(5–54) a | 15/7 | B |
Krasuski, RA, 2011 [12] | America, 1966–2007 | 0.14%(301/210700) | 57.7 ± 14.3 | 238/63 | B |
Xu,H, 2011 [13] | Asia, 2006–2011 | 0.57%(69/12145) | 57.6a | 51/18 | C |
Miller JA, 2012 [14] | America, 2004–2012 | NA (15) | 37.3 ± 18.9 | 10/5 | A |
Lee HJ, 2012 [15] | Asia, 2005–1020 | 0.68%(156/22925) | 56a | 124/32 | A, C |
Tuo G, 2013 [16] | European, 1994–2006 | 0.55%(44/7960) | 67 ± 7.2 | 14/30 | C |
Opolski MP, 2013 [17] | European, 2008–2012 | 0.84(72/8522) | 55 ± 12 | 20/53 | A, C |
Krupiński M, 2014 [18] | European, 6 consecutive years | 0.76% (54/7115) | 60.9 ± 11.6 | 16/38 | A |
Mainwaring RD, 2014 | America,1999–2013 | NA (69) | 15b | 47/22 | B |
Sharma V, 2014 [19] | America,1992–2011 | NA (75) | 39.6 ± 19.6 | 69/6 | B |
Poynter JA,2014 [20] | America,1998–2009 | NA (196) | 10.2a | 144/51 | B |
Ashrafpoor G. 2015 [21] | European,2008–2013 | 0.46%(19/4160) | 47.05 ± 9.75 | 16/38 | A |
Nasis A, 2015 [22] | Australia,2008–2013 | 1.09%(107/9774) | 58.1 ± 12.6 | 36/71 | A, C |
Kooij M, 2015 [23] | European,201–2014 | NA (31) | 38a | 26/5 | B |
Feins EN, 2015 [6] | America,1974–2014 | NA (259) | 42.5 ± 2.7 | 24/6/1 | B |
Cheezum MK, 2016 [24] | America,2004–2014 | 2.2% (131/5991) | 52 ± 17 | 45/63 | A |
Law Timothy, 2016 [5] | Australia,2002–2014 | NA (16) | 46.6 ± 16.1 | 16/0 | B |
Driesen BW, 2018 [25] | Netherlands, 2010–2017 | NA | 52 (36–64) | 25/5 | C |